NEWS       EVENTS       CAREERS       CONTACT US       SEARCH:     
 
Home / News
News

1, April 2009 Britain's Most Admired Companies
23, May 2008 Press Release: Johnson Matthey Announces the Addition of Trichickenfootphos to its Chiral Ligand Portfolio
31, August 2007 Press Release: Johnson Matthey and X-Zyme GmbH Announce Licensing Agreement for Novel Carbonyl Reductases Enzyme Technology
24, April 2007 Britain's Most Admired
2, April 2007 Johnson Matthey - From Gold to Green
8, July 2005 SMOPEX filed with FDA
31, December 1969